142 related articles for article (PubMed ID: 33706057)
1. Understanding and identifying immortal-time bias in surgical health services research: An example using surgical resection of stage IV breast cancer.
Jackson BE; Greenup RA; Strassle PD; Deal AM; Baggett CD; Lund JL; Reeder-Hayes KE
Surg Oncol; 2021 Jun; 37():101539. PubMed ID: 33706057
[TBL] [Abstract][Full Text] [Related]
2. The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example.
Duchesneau ED; Jackson BE; Webster-Clark M; Lund JL; Reeder-Hayes KE; Nápoles AM; Strassle PD
Cancer Epidemiol Biomarkers Prev; 2022 Nov; 31(11):2079-2086. PubMed ID: 35984990
[TBL] [Abstract][Full Text] [Related]
3. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site.
Cady B; Nathan NR; Michaelson JS; Golshan M; Smith BL
Ann Surg Oncol; 2008 Dec; 15(12):3384-95. PubMed ID: 18726129
[TBL] [Abstract][Full Text] [Related]
4. Association of surgery with improved survival in stage IV breast cancer patients.
Blanchard DK; Shetty PB; Hilsenbeck SG; Elledge RM
Ann Surg; 2008 May; 247(5):732-8. PubMed ID: 18438108
[TBL] [Abstract][Full Text] [Related]
5. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
6. SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation.
Ruiterkamp J; Voogd AC; Tjan-Heijnen VC; Bosscha K; van der Linden YM; Rutgers EJ; Boven E; van der Sangen MJ; Ernst MF;
BMC Surg; 2012 Apr; 12():5. PubMed ID: 22469291
[TBL] [Abstract][Full Text] [Related]
7. De novo Stage IV breast cancer: breast conserving resection of the primary tumor?
Khan SA
J Surg Oncol; 2014 Jul; 110(1):51-7. PubMed ID: 24760462
[TBL] [Abstract][Full Text] [Related]
8. Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.
Wang K; Shi Y; Li ZY; Xiao YL; Li J; Zhang X; Li HY
Eur J Surg Oncol; 2019 Aug; 45(8):1364-1372. PubMed ID: 30837102
[TBL] [Abstract][Full Text] [Related]
9. Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.
Jatoi I; Parsons HM
Breast Cancer Res Treat; 2014 Nov; 148(2):389-96. PubMed ID: 25301088
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis.
Fields RC; Jeffe DB; Trinkaus K; Zhang Q; Arthur C; Aft R; Dietz JR; Eberlein TJ; Gillanders WE; Margenthaler JA
Ann Surg Oncol; 2007 Dec; 14(12):3345-51. PubMed ID: 17687611
[TBL] [Abstract][Full Text] [Related]
11. [Locoregional surgery for stage IV breast cancer patients].
Lotersztajn N; Héquet D; Mosbah R; Rouzier R
Gynecol Obstet Fertil; 2015 Apr; 43(4):304-8. PubMed ID: 25819388
[TBL] [Abstract][Full Text] [Related]
12. Surgery of the primary tumor does not improve survival in stage IV breast cancer.
Dominici L; Najita J; Hughes M; Niland J; Marcom P; Wong YN; Carter B; Javid S; Edge S; Burstein H; Golshan M
Breast Cancer Res Treat; 2011 Sep; 129(2):459-65. PubMed ID: 21713372
[TBL] [Abstract][Full Text] [Related]
13. Better survival after surgery of the primary tumor in stage IV inflammatory breast cancer.
van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; Stam MR; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
Surg Oncol; 2020 Jun; 33():43-50. PubMed ID: 32561098
[TBL] [Abstract][Full Text] [Related]
14. Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?
Pérez-Fidalgo JA; Pimentel P; Caballero A; Bermejo B; Barrera JA; Burgues O; Martinez-Ruiz F; Chirivella I; Bosch A; Martínez-Agulló A; Lluch A
Breast; 2011 Dec; 20(6):548-54. PubMed ID: 21816613
[TBL] [Abstract][Full Text] [Related]
15. Immortal time bias exaggerates the effect of metformin on the risk of gastric cancer: A meta-analysis.
Wang YB; Tan LM; Luo L; Yan S; Huang Q; Wang Y; Deng T; Shi Y; Deng Y; Jin YH
Pharmacol Res; 2021 Mar; 165():105425. PubMed ID: 33453371
[TBL] [Abstract][Full Text] [Related]
16. Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data.
Maringe C; Benitez Majano S; Exarchakou A; Smith M; Rachet B; Belot A; Leyrat C
Int J Epidemiol; 2020 Oct; 49(5):1719-1729. PubMed ID: 32386426
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic mastectomy for the prevention of breast cancer.
Lostumbo L; Carbine N; Wallace J; Ezzo J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
[TBL] [Abstract][Full Text] [Related]
18. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.
Bafford AC; Burstein HJ; Barkley CR; Smith BL; Lipsitz S; Iglehart JD; Winer EP; Golshan M
Breast Cancer Res Treat; 2009 May; 115(1):7-12. PubMed ID: 18581232
[TBL] [Abstract][Full Text] [Related]
19. Changing indications for surgery in patients with stage IV breast cancer: a current perspective.
Morrogh M; Park A; Norton L; King TA
Cancer; 2008 Apr; 112(7):1445-54. PubMed ID: 18306353
[TBL] [Abstract][Full Text] [Related]
20. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?
Suissa S
Diabetes Care; 2018 Jan; 41(1):6-10. PubMed ID: 29263192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
